Such endpoints are referred to as biological markers, also known as biomarkers.
Such endpoints would be used as surrogates for the definitive endpoint.
Study design characteristics such as endpoints and statistical methods may also differ.
From these goals, decisions on specific clinical trial design elements, such as endpoint selection and statistical approaches, are formed.
Two patients were excluded afterwards because of missing data such as endpoint INR values and desired target INR values.
Additional endpoints (such as biomarkers), test systems (such as more generation tests), and multiple application as well as ageing of ENMs in the respective test medium are discussed.
This probably led to the dichotomization of originally continuous measures for use as trial endpoints, such as the 1.2 improvement in DAS28.
Late lumen loss, as determined by QCA, has been validated as a surrogate for clinical endpoints such as target vessel revascularization.
Of these some are clinical endpoints, such as overall survival, others use non-clinical endpoints, such as response to chemotherapy, many of which are considered to be surrogates for overall survival.
Strong endpoints, such as REILD, had a low incidence, while weaker endpoints, such as grade 3/4 toxicity, were heavily confounded by pretreatment morbidity, tumour cell type, and disease progression.
Event-free survival endpoints, such as DFS and PFS, were preferred to early treatment effect evaluation, such as R0 resection and response.
